Radiotherapy for bony manifestations of langerhans cell histiocytosis: Review and proposal for an international registry

Strahlentherapie und Onkologie

Volumn 182, Issue 2, 2006, Pages 72-79

  Olschewski, Thomas ^a   Seegenschmiedt, Michael Heinrich ^a  

^a ALFRIED KRUPP KRANKENHAUS   (Germany)

Author keywords

Adult Langerhans cell histiocytosis; Bony manifestations; Prospective radiotherapy registry; Radiotherapy

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; STEROID;

BONE LESION; CLINICAL FEATURE; CLINICAL TRIAL; DATA BASE; FOLLOW UP; HISTIOCYTOSIS X; HUMAN; IONIZING RADIATION; PROGNOSIS; PROSPECTIVE STUDY; REGISTER; REMISSION; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

BONE DISEASES; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; PROSPECTIVE STUDIES; REGISTRIES; TREATMENT OUTCOME;

EID: 31744445503     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-006-1357-7     Document Type: Review

References (55)

1. Anonsen CK, Donaldson SS. Langerhans' cell histiocytosis of the head and neck. Laryngoscope 1987;5:537-42.
2. Ardekian L, Peled M, Rosen D, et al. Clinical and radiographic features of eosinophilic granuloma in the jaws: review of 41 lesions treated by surgery and low-dose radiotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;87:238-42.
3. Arzoo K, Sadeghi S, Pullarkat V. Pamidronate for bone pain from osteolytic lesions in Langerhans'-cell histiocytosis. N Engl J Med 2001;345:225.
4. Baumgartner I, Hochstetter A von, Baumert B, et al. Langerhans cell histiocytosis in adults. Med Pediatr Oncol 1997;28:9-14.
5. Braier J, Chantada G, Rosso D, et al. Langerhans cell histiocytosis: retrospective evaluation of 123 patients at a single institution. Pediatr Hematol Oncol 1999;16:377-85.
6. Brown RE. More on pamidronate in Langerhans'-cell histiocytosis. N Engl J Med 2001;345:1503.
7. Capanna R, Springfield DS, Ruggieri P, et al. Direct cortisone injection in eosinophilic granuloma of bone: a preliminary report on 11 patients. J Pediatr Orthop 1985;5:339-42.
8. Cassady JR. Current role of radiation therapy in the management of histiocytosis X. Hematol Oncol Clin North Am 1987;1:123-9.
9. Ceci A, De Terlizzi M, Colella R, et al. Langerhans' cell histiocytosis in childhood: results from an Italian cooperative AIEOP-CNR-HX 83 study. Med Pediatr Oncol 1993;21:259-64.
10. Childs DS, Kennedy RL. Reticuloendotheliosis of children: treatment with roentgen therapy. Radiology 1951;57:653-8.
11. Cohen M, Zornoza J, Cangir A, et al. Direct injection of methylprednisolone sodium succinate in the treatment of solitary eosinophilic granuloma of bone: a report of 9 cases. Radiology 1980;136:289-93.
12. Culic S, Jakobson A, Culic V, et al. Etoposide as the basic and interferon-alpha as the maintenance therapy for Langerhans cell histiocytosis: a RTC. Pediatr Hematol Oncol 2001;18:291-4.
13. Egeler RM, de Kraker J, Voute PA. Langerhans-cel-histiocytosis (histiocytosis X); 20 jaar ervaring in het Emma Kinderziekenhuis, 1969-1988. Ned Tijdschr Geneeskd 1993;137:955-60.
14. El-Sayed S, Brewin TB. Histiocytosis X: does radiotherapy still have a role? Clin Oncol (R Coll Radiol) 1992;4:27-31.
15. Farran RP, Zaretski E, Egeler RM. Treatment of Langerhans cell histiocytosis with pamidronate. J Pediatr Hematol Oncol 2001;23:54-6.
16. Floman Y, Bar-On E, Mosheiff R, et al. Eosinophilic granuloma of the spine. J Pediatr Orthop 1997;6:260-5.
17. The French Langerhans' Cell Histiocytosis Study Group. A multicentre retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993. Arch Dis Child 1996;75:17-24.
18. Gadner H. Etoposide in Langerhans cell histiocytosis. Pediatr Hematol Oncol 1996;13:309-11.
19. Gadner H, Grois N, Arico M, et al. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. J Pediatr 2001;138:728-34.
20. Ghanem I, Tolo VT, D'Ambra P, et al. Langerhans cell histiocytosis of bone in children and adolescents. J Pediatr Orthop 2003;23:124-30.
21. Greenberger JS, Cassady JR, Jaffe N, et al. Radiation therapy in patients with histiocytosis: management of diabetes insipidus and bone lesions. Int J Radiat Oncol Biol Phys 1979;5:1749-55.
22. Greenberger JS, Crocker AC, Vawter G, et al. Results of treatment of 127 patients with systemic histiocytosis (Letterer-Siwe syndrome, Schuller-Christian syndrome and multifocal eosinophilic granuloma). Medicine (Baltimore) 1981;60:311-38.
23. Harms D, Müller KM. Histopathologische Aspekte der Langerhans-Zell-Histiozytose. Mit besonderer Berücksichtigung auch der pulmonalen LCH. Pathologe 2001;22:175-83.
24. Heyd R, Seegenschmiedt MH, Strassmann G, et al. Radiotherapy for Graves' orbitopathy: results of a national survey. Strahlenther Onkol 2003;179:372-6.
25. Howarth DM, Gilchrist GS, Mullan BP, et al. Langerhans cell histiocytosis. Diagnosis, natural history, management, and outcome. Cancer 1999;85:2278-90.
26. Kal HB, Veen RE. Biologically effective doses of postoperative radiotherapy in the prevention of keloids. Dose-effect relationship. Strahlenther Onkol 2005;181:717-23.
27. Kilpatrick SE, Wenger DE, Gilchrist GS, et al. Langerhans' cell histiocytosis (histiocytosis X) of bone. A clinicopathologic analysis of 263 pediatric and adult cases. Cancer 1995;76:2471-84.
28. Kinoshita K, Teshima T, Ohno Y, et al. Logical checking function increases the accuracy of data entry in the patterns of care study. Strahlenther Onkol 2003;179:107-12.
29. Kutzner J, Schneider L, Seegenschmiedt MH. Radiotherapy of keloids. Patterns of care study-results. Strahlenther Onkol 2003;179:54-8.
30. Ladisch S. Langerhans cell histiocytosis. Curr Opin Hematol 1998;5:54-8.
31. Ladisch S, Gadner H. Treatment of Langerhans cell histiocytosis - evolution and current approaches. Br J Cancer Suppl 1994;23:41-6.
32. Lieberman PH, Jones CR, Steinman RM, et al. Langerhans cell (eosinophilic) granulomatosis. A clinicopathologic study encompassing 50 years. Am J Surg Pathol 1996;20:519-52.
33. Liebmann A, Hindemith M, Jahns J, et al. Low-dose X-irradiation of adjuvant-induced arthritis in rats. Efficacy of different fractionation schedules. Strahlenther Onkol 2004;180:165-72.
34. Mackenzie WG, Morton KS. Eosinophilic granuloma of bone. Can J Surg 1988;31:264-7.
35. Martinez-Perez D, Mulliken JB, Arceci RJ. Langerhans cell histiocytosis: an uncommon disease commonly manifesting in the craniofacial skeleton. Plast Reconstr Surg 1996;98:211-6.
36. Mayer R, Sminia P, McBRide WH, et al. Lymphatic fistulas: obliteration by low-dose radiotherapy. Strahlenther Onkol 2005;181:660-4.
37. Micke O, Haidenberger A, Auer T, et al. Irradiation causes biphasic neutrophilic granulocyte phagocytic function. Strahlenther Onkol 2005;181:313-8.
38. Minkov M, Grois N, Braier J, et al. Immunosuppressive treatment for chemotherapy-resistant multisystem Langerhans cell histiocytosis. Med Pediatr Oncol 2003;40:253-6.
39. Minkov M, Grois N, Heitger A, et al. Response to initial treatment of multi-system Langerhans cell histiocytosis: an important prognostic indicator. Med Pediatr Oncol 2002;39:581-5.
40. Nauert C, Zornoza J, Ayala A, et al. Eosinophilic granuloma of bone: diagnosis and management. Skeletal Radiol 1983;10:227-35.
41. Pereslegin IA, Ustinova VF, Podlyashuk EL. Radiotherapy for eosinophilic granuloma of bone. Int J Radiat Oncol Biol Phys 1981;7:317-21.
42. Raney RB, D'Angio GT. Langerhans' cell histiocytosis (histiocytosis X): experience at the Children's Hospital of Philadelphia; 1970-1984. Med Pediatr Oncol 1989;17:20-8.
43. Rawlings CE 3rd, Wilkins RH. Solitary eosinophilic granuloma of the skull. Neurosurgery 1984;15:155-61.
44. Rivera-Luna R, Martinez-Guerra G, Altamirano-Alvarez E, et al. Langerhans cell histiocytosis: clinical experience with 124 patients. Pediatr Dermatol 1988;5:145-50.
45. Rodel F, Schaller U, Schultze-Mosgau S, et al. The induction of TGF-beta(1) and NF-kappaB parallels a biphasic time course of leukocyte/endothelial cell adhesion following low-dose X-irradiation. Strahlenther Onkol 2004;180:194-200.
46. Schuck A, Willich N. Langerhans-Zell-Histiozytose. In: Bamberg M, Molls M, Sack H, Hrsg. Radioonkologie, Bd 2: Klinik. München: Zuckschwerdt, 2004:1101.
47. Seegenschmiedt MH, Katalinic A, Makoski HB, et al. Radiotherapy of benign diseases: a patterns of care study in Germany. Strahlenther Onkol 1999;175:541-7.
48. Seegenschmiedt MH, Micke O, Willich N, and the German Cooperative Group on Benign Diseases (GCG-BD). Radiation therapy for nonmalignant diseases in Germany. Current concepts and future perspectives. Strahlenther Onkol 2004;180:718-30.
49. Selch MT, Parker RG. Radiation therapy in the management of Langerhans cell histiocytosis. Med Pediatr Oncol 1990;18:97-102.
50. Sessa S, Sommelet D, Lascombes P, et al. Treatment of Langerhans-cell histiocytosis in children. Experience at the Children's Hospital of Nancy. J Bone Joint Surg Am 1994;76:1513-25.
51. Titgemeyer C, Grois N, Minkov M, et al. Pattern and course of single-system disease in Langerhans cell histiocytosis. Data from the DAL-HX 83- and 90-study. Med Pediatr Oncol 2001;37:108-14.
52. Wester SM, Beabout JW, Unni KK, et al. Langerhans cell granulomatosis (histiocytosis X) of bone in adults. Am J Surg Pathol 1982;6:413-26.
53. Wiegel T, Sommer K, Knop J, et al. Strahlentherapie des solitären und multiplen eosinophilen Granuloms des Knochens (Stadium I). Strahlenther Onkol 1991;167:403-6.
54. Willis B, Ablin A, Weinberg V, et al. Disease course and late sequelae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco. J Clin Oncol 1996;14:2073-82.
55. Willman CL, Busque L, Griffith BB, et al. Langerhans' cell histiocytosis (histiocytosis X) - a clonal proliferative disease. N Engl J Med 1994;331:154-60.